From: Equitable access to cancer patient pathways in Norway – a national registry-based study
Lung | Colorectal | Prostate | Breast | |||
---|---|---|---|---|---|---|
Male | Female | Male | Female | |||
CPP patients: odds ratio of not receiving the cancer diagnosis. OR (95% CI) | ||||||
Age group | ||||||
Under 50 | 4.19 (3.19-5.52) | 2.89 (2.20-3.80) | 2.91 (2.50-3.38) | 2.29 (1.97-2.67) | 2.18 (1.75-2.73) | 5.97 (5.51-6.47) |
50-59 | 1.79 (1.52-2.12) | 1.31 (1.11-1.55) | 1.67 (1.49-1.87) | 1.47 (1.30-1.65) | 1.36 (1.25-1.49) | 1.76 (1.62-1.90) |
60-69 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
70-79 | 0.88 (0.78-0.99) | 0.87 (0.77-0.99) | 0.86 (0.79-0.94) | 0.81 (0.73-0.88) | 0.71 (0.66-0.75) | 1.03 (0.94-1.13) |
80-90 | 0.97 (0.84-1.12) | 1.13 (0.96-1.33) | 0.78 (0.70-0.87) | 0.59 (0.53-0.65) | 0.50 (0.45-0.57) | 0.69 (0.61-0.78) |
p-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Income | ||||||
Low | 0.76 (0.65-0.90) | 0.94 (0.77-1.14) | 0.96 (0.85-1.07) | 0.96 (0.85-1.09) | 1.02 (0.92-1.13) | 1.15 (1.05-1.26) |
Medium | 0.82 (0.72-0.93) | 0.91 (0.76-1.10) | 0.99 (0.91-1.08) | 0.99 (0.89-1.12) | 0.96 (0.90-1.03) | 1.10 (1.02-1.18) |
High | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
p-value† | 0.001 | 0.803 | 0.493 | 0.444 | 0.828 | 0.003 |
Education | ||||||
Low | 0.69 (0.60-0.81) | 0.74 (0.62-0.88) | 1.03 (0.93-1.14) | 1.00 (0.89-1.11) | 0.85 (0.78-0.93) | 1.08 (0.99-1.17) |
Medium | 0.80 (0.69-0.92) | 0.79 (0.67-0.92) | 1.00 (0.92-1.09) | 0.97 (0.88-1.07) | 0.90 (0.84-0.96) | 0.95 (0.89-1.02) |
High | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
p-value† | <0.001 | 0.003 | 0.54 | 0.955 | <0.001 | 0.146 |
Comorbidity | ||||||
Low | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Medium | 0.90 (0.80-1.02) | 0.79 (0.69-0.91) | 1.10 (0.99-1.23) | 1.14 (1.01-1.29) | 1.05 (0.94-1.18) | 1.29 (1.11-1.49) |
High | 0.90 (0.77-1.05) | 0.95 (0.78-1.15) | 1.20 (1.05-1.38) | 0.92 (0.78-1.08) | 1.25 (1.06-1.48) | 1.35 (1.11-1.65) |
p-value† | 0.07 | 0.025 | 0.003 | 0.826 | 0.008 | <0.001 |
Travel time | ||||||
Short | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Medium | 1.03 (0.89-1.19) | 0.92 (0.78-1.08) | 1.01 (0.90-1.12) | 0.93 (0.83-1.04) | 0.94 (0.86-1.03) | 1.13 (1.03-1.24) |
Long | 0.97 (0.80-1.16) | 0.94 (0.76-1.16) | 0.98 (0.86-1.12) | 1.02 (0.89-1.18) | 0.92 (0.82-1.04) | 1.08 (0.95-1.23) |
p-value† | 0.876 | 0.353 | 0.825 | 0.718 | 0.09 | 0.026 |
Hospital referral area‡ | ||||||
p-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Cancer patients: odds ratio of being included in CPP. OR (95% CI) | ||||||
Age group | ||||||
Under 50 | 1.14 (0.61-2.10) | 1.05 (0.60-1.85) | 0.41 (0.32-0.54) | 0.48 (0.37-0.63) | 0.98 (0.69-1.39) | 0.98 (0.78-1.24) |
50-59 | 1.14 (0.84-1.55) | 1.07 (0.80-1.43) | 0.98 (0.77-1.24) | 0.83 (0.65-1.05) | 0.96 (0.85-1.08) | 0.98 (0.80-1.20) |
60-69 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
70-79 | 1.02 (0.85-1.21) | 0.87 (0.73-1.05) | 0.99 (0.83-1.17) | 1.06 (0.89-1.28) | 0.84 (0.78-0.92) | 1.00 (0.81-1.25) |
80-90 | 0.55 (0.46-0.67) | 0.40 (0.33-0.49) | 0.73 (0.61-0.88) | 0.74 (0.62-0.89) | 0.34 (0.31-0.38) | 1.04 (0.80-1.35) |
p-value | <.001 | <.001 | <.001 | <.001 | <.001 | 0.996 |
Income | ||||||
Low | 0.59 (0.46-0.75) | 0.64 (0.45-0.90) | 0.77 (0.62-0.96) | 0.85 (0.67-1.09) | 0.82 (0.72-0.92) | 0.77 (0.60-0.98) |
Medium | 0.91 (0.73-1.14) | 0.73 (0.53-1.02) | 0.87 (0.73-1.02) | 0.88 (0.71-1.11) | 0.98 (0.90-1.06) | 0.99 (0.80-1.22) |
High | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
p-value† | <0.001 | 0.009 | 0.017 | 0.257 | 0.005 | 0.014 |
Education | ||||||
Low | 0.93 (0.73-1.19) | 0.97 (0.74-1.28) | 0.87 (0.71-1.05) | 0.91 (0.75-1.11) | 1.03 (0.93-1.15) | 0.84 (0.67-1.05) |
Medium | 0.92 (0.73-1.16) | 1.04 (0.80-1.36) | 0.94 (0.80-1.11) | 0.99 (0.83-1.19) | 1.12 (1.03-1.22) | 0.95 (0.78-1.14) |
High | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
p-value† | 0.699 | 0.555 | 0.142 | 0.281 | 0.407 | 0.124 |
Comorbidity | ||||||
Low | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Medium | 0.82 (0.69-0.98) | 0.80 (0.67-0.96) | 0.76 (0.63-0.91) | 0.68 (0.55-0.83) | 0.73 (0.65-0.82) | 0.96 (0.67-1.40) |
Much | 0.58 (0.48-0.70) | 0.41 (0.33-0.51) | 0.56 (0.45-0.70) | 0.61 (0.48-0.77) | 0.50 (0.43-0.59) | 0.72 (0.47-1.10) |
p-value† | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.165 |
Travel time | ||||||
Short | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Medium | 1.09 (0.88-1.35) | 1.19 (0.94-1.51) | 0.96 (0.78-1.18) | 0.98 (0.80-1.19) | 1.06 (0.96-1.18) | 1.11 (0.87-1.42) |
Long | 1.05 (0.80-1.37) | 0.85 (0.64-1.13) | 1.10 (0.85-1.43) | 0.98 (0.75-1.28) | 1.21 (1.06-1.39) | 0.78 (0.59-1.04) |
p-value† | 0.535 | 0.774 | 0.652 | 0.815 | 0.006 | 0.295 |
Hospital referral area‡ | ||||||
p-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |